We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
-0.32%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$6.4B
AUM Growth
-$2.91B
Cap. Flow
-$2.77B
Cap. Flow %
-43.38%
Top 10 Hldgs %
64.6%
Holding
239
New
57
Increased
26
Reduced
57
Closed
84

Sector Composition

Rank Sector Weight
1 Healthcare 12.92%
2 Technology 7.16%
3 Industrials 2.45%
4 Consumer Discretionary 2.31%
5 Materials 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVGO
126
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$642K 0.01%
+36,810
New +$1.11M
PS
127
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$632K 0.01%
37,600
+20,500
+120% +$441K
TPTX
128
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$564K 0.01%
+15,000
New +$653K
EVOP
129
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$557K 0.01%
+19,800
New +$581K
WAB icon
130
Wabtec
WAB
$49.3B
$539K 0.01%
+7,500
New +$533K
TENB icon
131
Tenable Holdings
TENB
$4.01B
$517K 0.01%
23,100
-6,900
-23% -$175K
ZUO
132
DELISTED
Zuora, Inc.
ZUO
$497K 0.01%
33,000
-167,090
-84% -$2.52M
MIST icon
133
Milestone Pharmaceuticals
MIST
$152M
$466K 0.01%
25,000
NET icon
134
Cloudflare
NET
$107B
$464K 0.01%
+25,000
New +$484K
ELAN icon
135
Elanco Animal Health
ELAN
$11.1B
$385K 0.01%
14,480
-8,017
-36% -$241K
CFB
136
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$358K 0.01%
+25,000
New +$360K
TUFN
137
DELISTED
Tufin Software Technologies Ltd.
TUFN
$329K 0.01%
+20,000
New +$411K
FATE icon
138
Fate Therapeutics
FATE
$326M
$311K ﹤0.01%
+20,000
New +$383K
ADAM
139
Adamas Trust
ADAM
$883M
$305K ﹤0.01%
+12,500
New +$308K
SWAV
140
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$299K ﹤0.01%
+10,000
New +$425K
WMGI
141
DELISTED
Wright Medical Group Inc
WMGI
$289K ﹤0.01%
14,000
MRNA icon
142
Moderna
MRNA
$23.6B
$271K ﹤0.01%
+17,000
New +$251K
AAL icon
143
CALL
American Airlines Group
AAL
$10.6B
$270K ﹤0.01%
10,000
NGM
144
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$265K ﹤0.01%
19,100
-2,000
-9% -$30K
IIIV icon
145
i3 Verticals
IIIV
$342M
$262K ﹤0.01%
13,000
-22,000
-63% -$541K
GSL icon
146
Global Ship Lease
GSL
$1.53B
$253K ﹤0.01%
+33,055
New +$243K
PTON icon
147
Peloton Interactive
PTON
$2.46B
$251K ﹤0.01%
+10,000
New +$254K
ROAD icon
148
Construction Partners
ROAD
$6.77B
$195K ﹤0.01%
+12,500
New +$187K
GE icon
149
CALL
GE Aerospace
GE
$384B
$179K ﹤0.01%
4,013
-4,012
-50% -$189K
CI icon
150
Cigna
CI
$74.6B
$152K ﹤0.01%
1,000
-96,734
-99% -$15.7M

Similar funds

Pentwater Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Pentwater Capital Management held 239 positions worth $6.4B, down 31% from $9.31B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Pentwater Capital Management withdrew a net $2.77B in Q3 2019, closing 84 positions and reducing 57 holdings. Its most notable exit was Anadarko Petroleum, an estimated $619M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Pentwater Capital Management opened a new position in Viacom Inc. Class B worth $48.1M.

  • Pentwater Capital Management's largest Q3 2019 buy was Viacom Inc. Class B: 2,000,100 shares worth $48.1M.
  • Pentwater Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $264M increase.
  • Pentwater Capital Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $582M.
  • Pentwater Capital Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $619M.
  • Pentwater Capital Management's ten largest holdings make up 65% of its $6.4B portfolio in Q3 2019.
  • Pentwater Capital Management opened 57 new positions and closed 84 in Q3 2019.
  • Pentwater Capital Management's portfolio value fell 31% quarter-over-quarter to $6.4B.

Based on Pentwater Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.